Tamtam Try Tamtam free
Penn Medicine, University of Pennsylvania Health System logo

Penn Medicine, University of Pennsylvania Health System account plan

Innovative healthcare research education

At a glance

Penn Medicine is the University of Pennsylvania's academic health system, with $10,204,994 thousand of FY2025 net patient service revenue.

Penn Medicine is the governance structure of the University of Pennsylvania that oversees its health system (UPHS) and the Perelman School of Medicine, combining clinical care, research and education. UPHS is not a separate legal entity: it is operated by the Trustees of the University, a not-for-profit founded in 1740. Its hospitals include the Hospital of the University of Pennsylvania, Penn Presbyterian, Pennsylvania Hospital, Chester County, Lancaster General Health, Princeton HealthCare System and, since April 1, 2025, Penn Medicine Doylestown Health. In FY2025 (year ended June 30, 2025) UPHS earned net patient service revenue of $10,204,994 thousand and an operating excess of $246,734 thousand; headcount is not stated in the documents. Kevin Mahoney is CEO of the health system and Julia Puchtler its CFO.

Business units

Strategic priorities

Technology and AI in care delivery
The CEO names AI, machine learning and automation to streamline diagnostics, treatment plans and routine tasks, and to remove administrative burdens from clinicians.
Location-flexible and virtual care
Penn Medicine is investing in outpatient care, telehealth and home care, and says care will be more virtual, with patients more open to staying close to home.
Regional growth closer to home
It added a seventh acute care hospital and names a new outpatient center in Montgomeryville, a proton therapy center in West Philadelphia, expanded cancer care in New Jersey and a mobile mammogram van.
Personalized medicine and translational research
Leaders tie research to clinical care, citing the Smilow Center for Translational Research, and prioritise treatments tailored with genetics and biotechnology.
Portfolio approach to investment
The CFO funds projects as a portfolio that must meet mission and financial criteria together, phasing projects without an immediate return so they can change course.

Investments and deals

Capital spending
The University's purchases of property, plant and equipment were $979,162 thousand in FY2025, with construction-in-progress of $760,649 thousand and capital commitments of approximately $452,073,000 at June 30, 2025.
New financing for the health system
After year end, Series A of 2025 bonds of $318,525,000 reimbursed UPHS $179,000,000 of capital expenditure, UPHS raised its revolving credit line to $200,000,000, added a second $100,000,000 line, and set up a taxable commercial paper programme of up to $300,000,000.
Doylestown Health integration
Penn Medicine took on $467,806 thousand of assets and $316,029 thousand of liabilities with Doylestown Health, including $174,814 thousand of long-term debt.
HUP-Cedar Avenue
Penn Medicine took over operations at HUP-Cedar Avenue in West Philadelphia after Mercy Philadelphia closed, adding an on-site food pantry and converting unused space into a ground-floor ambulatory practice.

Challenges and risks

Costs rising faster than revenue
UPHS total expenses rose to $11,748,880 thousand from $10,620,592 thousand in FY2025, compressing the operating excess.
Reimbursement uncertainty
Medicare and Medicaid rules are described as extremely complex, and third-party revenue is subject to audit and retroactive adjustment; the Aetna agreement rolled over only through June 30, 2026.
Malpractice exposure
A jury awarded $182,738,000 against UPHS in a fiscal year 2023 malpractice case, which UPHS has appealed; the gross professional liability was $856,770,000 at June 30, 2025.
Federal funding and new taxes
Research depends largely on governmental sources, and from fiscal year 2026 the University faces a 21% excise tax on executive pay over $1,000,000 and a 1.4% to 8% tax on net investment income.

What leadership says

“Healthcare is going to be more virtual, more telemedicine, and we're going to keep leaning in”

Kevin Mahoney, CEO, University of Pennsylvania Health System · The Daily Pennsylvanian, 7 September 2026

“we're focused on future-proofing so that we can adapt to unexpected challenges like funding changes, economic shifts and other pressures”

Kevin Mahoney, CEO, Penn Medicine · City & State Pennsylvania Q&A (sponsored content), 28 July 2025

“You can't do only things that don't have a return on investment ... It's a portfolio. So you're going to need things that do generate a return so that you can generate returns to fund the things that don't.”

Julia Puchtler, SVP and CFO, University of Pennsylvania Health System · The Daily Pennsylvanian, 7 September 2026

“Looking ahead, technology will transform the way we deliver care and work.”

Kevin Mahoney, CEO, Penn Medicine · City & State Pennsylvania Q&A (sponsored content), 28 July 2025

Where a supplier can help

Clinical AI and administrative automation
Tied to the technology and AI priority: tools that cut documentation and routine tasks for clinicians match the CEO's goal of removing administrative burdens, and help with costs rising faster than revenue.
Telehealth and home care platforms
Tied to the location-flexible care priority: virtual visit, remote monitoring and home care vendors fit a system that plans to keep leaning into telemedicine.
Outpatient and facility build-out
Tied to regional growth and capital spending: equipment, construction and facility technology suppliers can support new outpatient, proton therapy and cancer care sites; phased proposals suit the CFO's portfolio approach.
Revenue cycle and payer analytics
Tied to reimbursement uncertainty: revenue cycle, denials and value-based contract analytics help with complex Medicare and Medicaid rules and the Aetna and Independence Blue Cross contracts.
Integration of Doylestown Health
Tied to the Doylestown Health integration: IT, supply chain and clinical systems integration services can help bring a newly joined hospital onto Penn Medicine's platforms.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Penn Medicine, University of Pennsylvania Health System?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Penn Medicine, University of Pennsylvania Health System

What is Penn Medicine?

Penn Medicine is the University of Pennsylvania structure that oversees its health system (UPHS) and the Perelman School of Medicine, coordinating clinical care, research and education.

What is Penn Medicine's revenue?

In FY2025 (year ended June 30, 2025) UPHS earned net patient service revenue of $10,204,994 thousand and other revenue and support of $1,790,620 thousand, with an operating excess of $246,734 thousand.

Who leads Penn Medicine?

Kevin Mahoney is CEO of the University of Pennsylvania Health System and Julia Puchtler is its Senior Vice President and CFO; the Trustees of the University govern it.

What is Penn Medicine's strategy?

Its leaders prioritise AI and automation, location-flexible and virtual care, regional growth through outpatient sites and new hospitals, and translational research tied to patient care.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)